Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis - Wikidata - awgldk - TriplyDB

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

http://www.wikidata.org/entity/Q33355906

about

Identification of autoantibodies against transthyretin for the screening and diagnosis of rheumatoid arthritis Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab.Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease Proteomic analysis reveals platelet factor 4 and beta-thromboglobulin as prognostic markers in severe acute respiratory syndrome.Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure.Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis.Generation and Characterization of a New Monoclonal Antibody Against CXCL4.Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response.Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis.Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.Proteomics in rheumatology: the dawn of a new era.Biomarkers of rheumatoid arthritis: recent progress.Platelets and autoimmunity.A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.Proteomics to predict the response to tumour necrosis factor-α inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.Dynamics shared by two related proinflammatory conditions, rheumatoid arthritis and metabolic syndrome.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Serum protein profile of Crohn's disease treated with infliximab.Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.

P2860

Q28542099-79AF7FC3-CED4-4EC3-B66D-04A40968325E Q28551216-B2533AF7-8006-41DE-A7A0-2CFD814F35CD Q31090628-FB49F904-925D-49FC-AF5A-8D789B64C663 Q33518313-61E2265A-B3A3-4193-9493-FABE76816C1F Q33520447-A28CA251-BCE3-4BB6-896C-27166790B5C3 Q33597457-325B6941-4453-4571-AB3C-D836F415DC95 Q34319548-C29C7A88-71EC-4A7F-9815-897A77085F14 Q34613963-B05C7927-8C02-43E6-9A7B-2BE8636CE445 Q34662086-BA1A6F81-17BB-4332-91BC-82A3FABEEB0E Q34688901-DCF4F06B-A9E6-4C59-8D95-97B8BBA25DD7 Q35247643-54028C5D-A9A8-4435-81FD-49CE19D54D5B Q35540003-336068BD-EC70-4F33-B5EB-A29C01EF0A69 Q35900864-9E378D5C-E792-4702-8008-C6FC5497502D Q35907845-163477BF-CF06-4A12-99AA-9783809E205C Q36056195-B05AA9EA-5DB6-4C07-8B7A-D7FDB673EACA Q37728019-0A5EC1D1-EA73-4764-905B-BFEFC0E84756 Q37730557-03DB380C-50E4-4DF1-B40F-1B2BEB7149B7 Q37830007-8BE2B3DB-3D80-493D-8813-C6D802B19D91 Q37833923-C599F7FC-88FD-49FF-82F0-692B3DDFE540 Q38089869-5C138D09-6253-453B-8CD6-4EDAEDDD77E9 Q38101678-1DFBB52B-9C14-448A-AAEC-8777D92DB01A Q39088676-6DF5EDA4-C4CD-424D-A209-11D2807D8390 Q39218194-55469DB0-9500-4261-9392-083E17F2A0E2 Q40145642-1D1BB42A-3CC4-480A-A16B-C4E16710995B Q42389660-77CF7ED0-A73E-487B-9BD8-08EADA450E63 Q42633541-E9018595-6405-4410-814B-F7C830BF4BDD Q45886414-8B2E8D83-5769-4844-BB9C-32E9BA5D2AE5 Q50210105-D3A22801-437E-4566-B706-E18720707F1F Q53212565-57935848-596C-482D-9D20-708536500B51

P2860

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

http://www.wikidata.org/entity/Q33355906

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@ast

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@en

type

label

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@ast

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@en

prefLabel

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@ast

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@en

P1433

Q33355906-F28350B2-2E62-4DC9-B905-0E954AA300C8

P1476

Q33355906-F52A9F59-7E92-47B1-BA39-173ACAFCEE5D

P2093

Q33355906-0D30D187-64F5-49B9-95F4-E8BD770A3215

Q33355906-2E62D304-5124-451C-903C-F8D7636C895E

Q33355906-5AE80433-E884-4CAF-87A8-A6B67EA23E3C

Q33355906-9280EF3B-5706-4B38-A236-D2F7B0266FCD

Q33355906-981CEEF3-9FAC-490E-AA03-871F97085988

Q33355906-A55D6676-1724-4904-8702-22055BFB7F06

Q33355906-B9E68F95-8B7C-44CF-827B-ACC59294D3A5

Q33355906-C7009194-EF43-46E3-B7AB-2909B60DEC92

Q33355906-CD6474DF-4D98-4BD3-A291-93F3CAF0D66A

Q33355906-D47E27E3-7D9E-4618-B214-E855A5F0A105

P2860

Q33355906-0A4848BF-D99C-40BB-8696-2283CE430379

Q33355906-129437A7-7745-4F7C-9327-6FE3578842B0

Q33355906-1680C49F-B5D0-46C1-8019-2695EC55B124

Q33355906-1B364BCA-E4A5-4843-A944-8A53D90F0E56

Q33355906-29FB6DF8-4A2C-4833-A250-E8A5820113E3

Q33355906-2C6D2CA9-B3AA-4DBF-A664-0D399A2503EF

Q33355906-2CDD5FB8-4B75-4F97-A44B-FE9B224AE29F

Q33355906-38D94AB8-9094-4EEB-B7C7-80AB6C1DEE42

Q33355906-4AC58DA3-BBB2-4242-9FCD-5DC2910A3537

Q33355906-5997AB59-47DC-495B-8AB2-9180E98F041E

P304

Q33355906-0C5479A9-8906-4FD4-A2A5-E183657DBAF4

P31

Q33355906-EB157E73-1BC0-486A-AFD5-9B53F089C28B

P356

Q33355906-A704FCE4-591A-4588-9CE7-6FBF1B0D9BC0

P407

Q33355906-ACDA9CBD-9CEF-4550-9CC5-76D50963016E

P433

Q33355906-28C898C8-C43C-4C60-875D-1EEB833EDF06

P478

Q33355906-13B190EC-7933-4CE2-8FD6-E7700770722C

P50

Q33355906-ADA1DB05-7088-4367-A11E-D268BA32797A

P577

Q33355906-77B293B4-AA93-4F01-B466-74A011436641

P698

Q33355906-7E6F1343-E0EA-46B3-B9EE-EAAC4E3B184F

P921

Q33355906-D459F457-AEF3-4432-8C79-E0FE0C1A0DB7

P932

Q33355906-15F9F4EE-BBD0-4A0A-8EC7-5BCA6A9691FD

P356

ARD.2008.093153

P1433

Annals of the Rheumatic Diseases

P1476

Apolipoprotein A-I and platele ...... sponse in rheumatoid arthritis

@en

P2093

A Baillet

http://www.w3.org/2001/XMLSchema#string

B Pallot-Prades

http://www.w3.org/2001/XMLSchema#string

C Trocmé

http://www.w3.org/2001/XMLSchema#string

F Berger

http://www.w3.org/2001/XMLSchema#string

F Morel

http://www.w3.org/2001/XMLSchema#string

H Marotte

http://www.w3.org/2001/XMLSchema#string

J Garin

http://www.w3.org/2001/XMLSchema#string

J Tebib

http://www.w3.org/2001/XMLSchema#string

L Grange

http://www.w3.org/2001/XMLSchema#string

M J Nissen

http://www.w3.org/2001/XMLSchema#string

P2860

The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages

Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.

Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid.

Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.

Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics

Proteome studies of CSF in AD patients.

P304

1328-1333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2008.093153

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18664547

http://www.w3.org/2001/XMLSchema#string

P921

P932

2921545

http://www.w3.org/2001/XMLSchema#string